Remove Bone Scan Remove Disease Remove PET Scan
article thumbnail

PSMA-PET superior to MRI in phase II prostate cancer trial

AuntMinnie

Participants underwent both F-18 PSMA-1007 PET/CT and multiparametric MRI within 14 days of one another and at least five days before surgery at two hospitals in Alberta, Canada. Out of 150 men who participated, 134 ultimately underwent radical prostatectomies (the mean age was 62 years old). The full study is available here.

MRI 105
article thumbnail

The rise of theranostics: Part 4 -- Women's theranostics on the horizon

AuntMinnie

In addition, the mean tissue dose did not reach the maximum tolerated dose for kidney, bone marrow, or liver. Three grade 3 CAM-H2 treatment emergent adverse events (TEAE) were reported in three patients who had a previous history of thrombocytopenia, lung disease, or liver disease, with no grade 4 or 5 adverse events reported.

Disease 105